HIV/AIDS
Reports from University of Sydney describe recent advances in HIV/AIDS
Published in AIDS Weekly, April 27th, 2009
"In a review of integrase inhibitor-naive Australian HIV-1 sequences, primary mutations were not identified, although the accessory mutation G140S was detected. A link with previous antiretroviral therapy, intra-subtype B divergence across the integrase gene and transmission of integrase polymorphisms were also noted," wrote S.J. Vanhal and colleagues, University of Sydney.
The researchers concluded: "Based on these findings, we would recommend ongoing surveillance of integrase mutations, and integrase...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2009-04-27)
More Articles from AIDS Weekly
- Idibaps - Institut d'Investigacions Biomediques August Pi i Sunyer
Early administration of antiretroviral therapy can improve survival - McGill University Health Centre
Treating HIV earlier to decrease the risk of death - Rockefeller University Press
HIV pays a price for invisibility - University of California - San Diego
Tijuana injection drug users on collision course for HIV and TB - AuthorHouse
'Understanding Life Settlements': New Guidebook Offers Valuable Advice for Cashing in Life Insurance Policies - Now! - Drug Development
New data from D.J. Huggins et al illuminate research in drug development - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
